- Home
- CIGL vs SER Comparison
CIGL vs SER Comparison
Compare CIGL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIGL
- SER
- Stock Information
- Founded
- CIGL 1997
- SER 2017
- Country
- CIGL Singapore
- SER United States
- Employees
- CIGL N/A
- SER N/A
- Industry
- CIGL Diversified Commercial Services
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- CIGL Consumer Discretionary
- SER Health Care
- Exchange
- CIGL Nasdaq
- SER Nasdaq
- Market Cap
- CIGL 46.7M
- SER 55.2M
- IPO Year
- CIGL 2025
- SER 2018
- Fundamental
- Price
- CIGL $2.89
- SER $5.39
- Analyst Decision
- CIGL
- SER Strong Buy
- Analyst Count
- CIGL 0
- SER 2
- Target Price
- CIGL N/A
- SER $13.00
- AVG Volume (30 Days)
- CIGL 3.2M
- SER 24.9K
- Earning Date
- CIGL 09-29-2025
- SER 11-11-2025
- Dividend Yield
- CIGL N/A
- SER N/A
- EPS Growth
- CIGL N/A
- SER N/A
- EPS
- CIGL N/A
- SER N/A
- Revenue
- CIGL $11,072,733.00
- SER $130,000.00
- Revenue This Year
- CIGL N/A
- SER $17.23
- Revenue Next Year
- CIGL N/A
- SER N/A
- P/E Ratio
- CIGL N/A
- SER N/A
- Revenue Growth
- CIGL 6.32
- SER N/A
- 52 Week Low
- CIGL $1.40
- SER $3.81
- 52 Week High
- CIGL $31.06
- SER $8.14
- Technical
- Relative Strength Index (RSI)
- CIGL N/A
- SER 55.25
- Support Level
- CIGL N/A
- SER $5.09
- Resistance Level
- CIGL N/A
- SER $5.49
- Average True Range (ATR)
- CIGL 0.00
- SER 0.25
- MACD
- CIGL 0.00
- SER 0.05
- Stochastic Oscillator
- CIGL 0.00
- SER 83.84
About CIGL Concorde International Group Ltd Class A Ordinary Shares
Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.